INS and cancer: In model 1, among new onset diabetics with no history of cancer, variables that may indicate the severity of diabetes at the time of diagnosis, such as a visit to an endocrinologist, purchase of oral diabetic medication and purchase of insulin treatment were associated with mortality (HR 1.20 95% CI 1.